Products Pinaverium bromide is commercially available in the form of film-coated tablets (Dicetel). It has been approved in many countries since 1985. Structure and properties Pinaverium bromide (C26H41Br2NO4, Mr = 591.4 g/mol) Effects Pinaverium bromide (ATC A03AX04) is antispasmodic with selective action on the digestive tract. It is a calcium antagonist and inhibits calcium influx … Pinaverium Bromide
Products Spasmolytics are commercially available in the form of tablets, suppositories, and injectables, among others. In many countries, scopolamine butylbromide is among the best-known representatives. Structure and properties Spasmolytics are often derived from the tropane alkaloids atropine and scopolamine from nightshade plants or from the benzylisoquinoline papaverine from the opium poppy. Effects Spasmolytics have spasmolytic … Spasmolytics
Products Drofenine is registered for export in tablet form (Lunadon, combination). It has been approved in many countries since 1977 but is not commercially available. Structure and properties Drofenine (C20H31NO2, Mr = 317.47 g/mol) is a derivative of atropine. It exists as drofenine hydrochloride, a white, loose crystalline powder that is very soluble in water. … Drofenin
Products Mebeverine is commercially available in the form of sustained-release capsules (Duspatalin Retard). It has been approved in many countries since 1967. Structure and properties Mebeverine (C25H35NO5, Mr = 429.6 g/mol) is an open-chain derivative of papaverine. It is present in drugs as mebeverine hydrochloride, a white crystalline powder that is very soluble in water. … Mebeverin
Symptoms Gallstones manifest as pain and cramping below the breastbone and in the right upper abdomen. The pain may also radiate to the back and shoulders. Biliary colic with stones in the bile ducts causes unbearable discomfort. Possible complications include inflammation of the gallbladder, bacterial infection, fever, blockage of the bile ducts with jaundice, inflammation … Gallstones Causes and Treatment
Products Flavoxate is commercially available in the form of film-coated tablets (Urispas). It has been approved in many countries since 2008. Structure and properties Flavoxate (C24H25NO4, Mr = 391.5 g/mol) is present in drugs as flavoxate hydrochloride, an oxo-benzopyran and piperidine derivative. An active metabolite is involved in the effects. Effects Flavoxate (ATC G04BD02) has … Flavoxat
